Explanatory note
(This note is not part of the Regulations)
These Regulations require the Care Quality Commission to conduct periodic reviews of the carrying on of a regulated activity in England by NHS Blood and Transplant, a Special Health Authority established by S.I. 2005/2529. The regulated activity to be reviewed, set out in regulation 3 of the Health and Social Care Act 2008 (Registration of Regulated Activities) Regulations 2009 (S.I. 2009/660), is the management by NHS Blood and Transplant of―
the supply of blood, blood components and blood derived products intended for transfusion;
the supply of tissues and tissue derived products intended for transplant, grafting or use in a surgical procedure; and
the matching and allocation of donor organs intended for transplant, and of stem cells and bone marrow intended for transfusion.
Following each such review, the Commission is required to assess the performance of NHS Blood and Transplant and publish a report of its assessment.
A full regulatory impact assessment has not been produced for this instrument as no impact on the private or voluntary sectors is foreseen.